PMC:7128678 / 26461-26637
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 787 | 99-104 | Species | denotes | human | Tax:9606 |
| 788 | 138-148 | Species | denotes | SARS-CoV-2 | Tax:2697049 |
| 792 | 4-14 | Chemical | denotes | asparagine | MESH:D001216 |
LitCovid-PMC-OGER-BB
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T580 | 48-53 | SO:0000162 | denotes | sites |
| T581 | 99-104 | SP_6;NCBITaxon:9606 | denotes | human |
| T582 | 109-115 | NCBITaxon:33208 | denotes | animal |
| T583 | 116-123 | NCBITaxon:10239 | denotes | viruses |
| T584 | 138-148 | SP_7 | denotes | SARS-CoV-2 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T127 | 138-146 | Disease | denotes | SARS-CoV | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T209 | 82-83 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | b |
| T210 | 99-104 | http://purl.obolibrary.org/obo/NCBITaxon_9606 | denotes | human |
| T211 | 109-115 | http://purl.obolibrary.org/obo/NCBITaxon_33208 | denotes | animal |
| T212 | 116-123 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T213 | 171-174 | http://purl.obolibrary.org/obo/CLO_0001002 | denotes | 162 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T657 | 4-14 | Chemical | denotes | asparagine | http://purl.obolibrary.org/obo/CHEBI_22653 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T10 | 34-47 | http://purl.obolibrary.org/obo/GO_0070085 | denotes | glycosylation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T211 | 0-176 | Sentence | denotes | Two asparagine residues acting as glycosylation sites are highlighted in yellow. (b) Alignments of human and animal viruses compared with SARS-CoV-2 (6VSB_A, fragment 111–162). |